Thalmann, George N

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

James, N. D., Sydes, M. R., Mason, M. D., Clarke, N. W., Anderson, J., Dearnaley, D. P., Dwyer, J., Jovic, G., Ritchie, A. W., Russell, J. M., et al. (2012) · The Lancet Oncology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 123

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial

Dal Pra, A., Ghadjar, P., Hayoz, S., Liu, V. Y. T., Spratt, D. E., Thompson, D. J. S., Davicioni, E., Huang, H.-C., Zhao, X., Liu, Y., et al. (2022) · Annals of Oncology

Prostate Cancer Diagnosis and TreatmentBreast Cancer Treatment Studies

Cited by 65